Plain-English translation of NCT07241767 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Lung Cancer research guide →Phase 2 — Testing in a bigger group (up to a few hundred people) to see if the treatment actually works and is still safe.
This trial is testing a new medication called FH-006 in combination with other standard cancer treatments for people with advanced lung cancer that cannot be treated with surgery or radiation alone. Researchers want to understand how safe this medication is, how well patients tolerate it, and whether it helps control the cancer. The study will also help doctors determine the best dose of this treatment to use.
Current treatments for advanced lung cancer don't work for everyone, and some patients experience serious side effects. This trial is exploring whether adding this medication to standard treatments might help more patients and improve outcomes.
You likely qualify if…
You likely don't qualify if…
As a participant, you would receive FH-006 combined with other approved cancer treatments at a hospital or clinic as part of a structured treatment plan. The study involves regular visits for physical exams, blood tests, and imaging scans to monitor how the medication is working and check for side effects. Your doctors will watch closely for any safety concerns and may adjust your dose based on how you respond.
AI-generated summary from trial data · Jun 6, 2026 · Not medical advice
China